Tag: TCT 2021
Interventional News’ top 10 most popular stories of November 2021
November’s top 10 features a pilot study regarding cryoablation for the treatment of early-stage, low-risk breast tumours, as well as data indicating that the Ellipsys vascular access...
IN.PACT Admiral DCB performs well across wide range of clinical and...
In a pooled analysis of the predictors of drug-coated balloon (DCB) effectiveness, the IN.PACT Admiral DCB (Medtronic) performed well across a broad range of...
TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal...
Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasound renal denervation to a sham procedure for treatment-resistant hypertension, demonstrate the additional effects...
Medtronic unveils data on hypertension treatment preferences, launches SPYRAL AFFIRM study
Medtronic today announced findings from a new study of patient preferences for the treatment of hypertension. The findings are set to be presented during...
